| (Values in U.S. Thousands) | Dec, 2020 | Dec, 2019 | Dec, 2018 | May, 2026 | May, 2026 |
| Sales | 11,650 | 50,000 | 0 | 0 | 0 |
| Sales Growth | -76.70% | unch | unch | unch | unch |
| Net Income | -150,670 | -86,430 | -190,270 | 0 | 0 |
| Net Income Growth | -74.33% | +54.58% | unch | unch | unch |
Viela Bio Inc (VIE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Viela Bio Inc. is a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases. Viela Bio Inc. is headquartered in Gaithersburg, Maryland.
Fiscal Year End Date: 12/31